iShares Health Innovation Active ETF (BMED) Fund Overview
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 18, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnsweriShares Health Innovation Active ETF (BMED) trades at $33.74. The iShares Health Innovation Active ETF aims to maximize total return by investing in innovative and emerging companies within the healthcare sector. Sector: Financials.
Price as of · Last analyzed: Mar 18, 2026Analyst Coverage for BMED: BMED does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
iShares Health Innovation Active ETF (BMED) Financial Services Profile
iShares Health Innovation Active ETF (BMED) focuses on maximizing total return through investments in innovative and emerging healthcare companies. As an actively managed ETF, BMED offers targeted exposure to the healthcare sector's dynamic landscape, providing investors with a specialized investment vehicle within the asset management industry.
What Is the Investment Thesis for BMED?
The iShares Health Innovation Active ETF (BMED) presents an investment opportunity centered on the growth potential of innovative healthcare companies. The fund's active management strategy allows for dynamic allocation to emerging trends and disruptive technologies within the healthcare sector. Key value drivers include the increasing demand for healthcare innovation, driven by an aging global population and advancements in medical technology. Catalysts include regulatory approvals for new therapies and devices, strategic partnerships, and successful product launches. Potential risks include regulatory hurdles, clinical trial failures, and competitive pressures within the healthcare industry. The fund's focus on innovation offers exposure to high-growth segments, but also introduces volatility associated with early-stage companies and evolving technologies.
Based on FMP financials and quantitative analysis
BMED Key Highlights
BMED focuses on innovative and emerging companies in the healthcare sector, offering targeted exposure to high-growth segments.
- The fund is actively managed, allowing for flexibility in investment decisions and adaptation to changing market conditions.
- BMED's investment strategy aims to maximize total return by capitalizing on opportunities within the rapidly evolving healthcare landscape.
- The ETF provides a diversified portfolio of healthcare innovators, reducing risk compared to investing in individual companies.
- Managed by BlackRock, a leading global asset management firm, leveraging their expertise and resources in healthcare investing.
Who Are BMED's Competitors?
BMED is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| BLK BlackRock, Inc. | $1069.63 | -0.91% | $167B | 52 5-pillar |
| BX Blackstone Inc. | $111.80 | -1.38% | $135B | 69 5-pillar |
| APOS Apollo Global Management, Inc. | $25.43 | -0.66% | $74.6B | 56 5-pillar |
| BAM Brookfield Asset Management | $44.50 | -1.57% | $72.2B | 57 5-pillar |
| AMP Ameriprise Financial, Inc. | $490.46 | -1.24% | $44.1B | 78 5-pillar |
| ARES Ares Management Corporation | $115.75 | -1.69% | $38.0B | 57 5-pillar |
| TROW T. Rowe Price Group, Inc. | $104.07 | +0.45% | $22.3B | 80 5-pillar |
| ATHS Athene Holding Ltd. | $23.36 | -0.61% | $18.7B | 56 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are BMED's Key Strengths?
Focus on innovative and emerging healthcare companies.
- Active management strategy.
- Diversified portfolio.
- Expertise of BlackRock.
What Are BMED's Weaknesses?
Higher expense ratio compared to passive ETFs.
- Potential for underperformance compared to benchmark indices.
- Reliance on the expertise of the portfolio managers.
- Vulnerability to market volatility in the healthcare sector.
What Are the Key Risks for BMED?
Regulatory hurdles and delays in drug approvals.
- Clinical trial failures and product recalls.
- Competitive pressures from other healthcare companies.
- Market volatility and economic uncertainty.
- Changes in healthcare policy and reimbursement rates.
What Are BMED's Competitive Advantages?
- Expertise of BlackRock in healthcare investing.
- Active management strategy allows for flexibility and adaptation to market changes.
- Diversified portfolio reduces risk compared to investing in individual companies.
- Targeted exposure to innovative and emerging healthcare companies.
What Does BMED Do?
The iShares Health Innovation Active ETF (BMED) is designed to provide investors with exposure to the innovative and emerging segments of the healthcare industry. As an actively managed exchange-traded fund, BMED seeks to achieve maximum total return by strategically investing in companies that are at the forefront of healthcare advancements. The fund's investment strategy focuses on identifying and capitalizing on opportunities within the rapidly evolving healthcare sector, which includes biotechnology, pharmaceuticals, medical devices, healthcare technology, and related fields. BMED aims to provide a diversified portfolio of healthcare innovators, allowing investors to participate in the potential growth and advancements within this critical sector. The fund's active management approach allows for flexibility in investment decisions, enabling the portfolio managers to adapt to changing market conditions and identify emerging trends within the healthcare industry. By focusing on innovation, BMED seeks to capture the long-term growth potential of companies that are driving advancements in healthcare technology, treatments, and services. The ETF is managed by BlackRock, a leading global asset management firm, leveraging their expertise and resources in healthcare investing.
What Products and Services Does BMED Offer?
- Invests in innovative and emerging companies in the healthcare sector.
- Seeks to maximize total return through strategic asset allocation.
- Provides investors with targeted exposure to the healthcare industry.
- Actively manages a portfolio of healthcare stocks.
- Focuses on companies driving advancements in healthcare technology and services.
- Offers a diversified investment vehicle for participating in the growth of the healthcare sector.
How Does BMED Make Money?
- Generates revenue through management fees charged to investors.
- Invests in a portfolio of healthcare companies to generate capital appreciation.
- Utilizes an active management strategy to identify and capitalize on investment opportunities.
- Distributes capital gains to investors.
What Industry Does BMED Operate In?
The asset management industry is characterized by a diverse range of investment vehicles, including ETFs, mutual funds, and hedge funds. The iShares Health Innovation Active ETF (BMED) operates within this landscape, focusing specifically on the healthcare sector. The healthcare industry is experiencing significant growth, driven by factors such as an aging population, technological advancements, and increasing healthcare spending. BMED's focus on innovation positions it to capitalize on these trends, while also navigating the competitive landscape of other healthcare-focused investment products.
Who Are BMED's Key Customers?
- Individual investors seeking exposure to the healthcare sector.
- Institutional investors looking for diversified healthcare investments.
- Financial advisors seeking to provide clients with healthcare-focused investment options.
- Retirement funds and pension plans.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● No filing on record
- ● No analyst coverage
- ● This is an etf, not an operating company
MoonshotScore History
Recorded daily since 2026-08-23 · 43 snapshots
| 2026-08-23 | 49 |
| 2026-08-31 | 49 |
| 2026-09-08 | 49 |
| 2026-09-16 | 49 |
| 2026-09-24 | 49 |
| 2026-10-04 | 49 |
| 2026-10-06 | 49 |
What changed?
The score has stayed at 49.
Over the same 30 days the stock moved -0.1%.
BMED Financials
Bull Case vs Bear Case
Bull Case
- Focus on innovative and emerging healthcare companies.
- Active management strategy.
- Diversified portfolio.
- Expertise of BlackRock.
Bear Case
- Higher expense ratio compared to passive ETFs.
- Potential for underperformance compared to benchmark indices.
- Reliance on the expertise of the portfolio managers.
- Vulnerability to market volatility in the healthcare sector.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
BMED Latest News
No recent news available for BMED.
BMED Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for BMED.
Price Targets
Wall Street price target analysis for BMED.
BMED MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for BMED; grades run from A+ (80-100) to F (below 30).
Common Questions About BMED (Financials)
What does iShares Health Innovation Active ETF do?
The iShares Health Innovation Active ETF (BMED) is an actively managed fund that invests in companies at the forefront of healthcare innovation.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- The information provided is based on available data and may be subject to change.
- Investment decisions should be made based on individual risk tolerance and financial circumstances.